Ganirelix acetateProduct ingredient for Ganirelix

Ganirelix is a synthetic decapeptide and a competitive gonadotropin-releasing hormone (GnRH) antagonist. Derived from endogenous GnRH, ganirelix has amino acid substitutions. Ganirelix is indicated for controlled ovarian hyperstimulation in assisted reproduction techniques.⁵ The first case of pregnancy achieved after the use of ganirelix in an assisted reproduction program was reported in 1998.² Ganirelix was first approved by the FDA on July 29, 1999.⁷